is hers going to stop selling semaglutide Hims & Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks Hims & Hers Stock Pops

Lifestyle Interventions with Retatrutide

May 12, 2025: More Patients Sue Because of Side Effects of Ozempic and GLP-1 Products There are 1,809 lawsuits pending against the companies that made and sold Ozempic, the semaglutide medicine used to treat things like diabetes and obesity

Li CJ et al

The heterogeneity of study designs, from single case reports to retrospective database analyses, further challenges causal inference

In patients who received background basal insulin or basal insulin plus MET, reduction in SBP and DBP was observed in all treatment groups

Further study is needed to elucidate whether the renoprotective effects of semaglutide are consistent in those individuals